Speaker Profile
Biography
Dr. Mahdi Moqri is a faculty member at Harvard Medical School and an independent investigator at the Division of Genetics as well as the Endocrinology, Diabetes, and Metabolism. His research integrates omics, bioinformatics, and computational methods to uncover the molecular mechanisms of aging and to develop new approaches for early detection and prevention of age-related diseases. Dr. Moqri co-directs the Biomarkers of Aging Consortium (agingconsortium. org), where he leads efforts to develop blood-based biomarkers of aging using large-scale omics datasets and longitudinal biobank resources. He completed his postdoctoral fellowship at Stanford University in the Snyder Lab, and his formal training is in computer science and informatics. Dr. Moqri looks forward to starting new collaborations with colleagues across the division.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair:
Michael Goldman, SFSU
PMWC Award Ceremony
• David Sinclair, Harvard
• Steve Horvath, Altos Labs
• Nir Barzilai, Albert Einstein College of Medicine
AI-Driven Biomarkers to Quantify Aging
• Chair: Alex Zhavoronkov, Insilico Medicine
• Mahdi Moqri, Harvard
• Steve Horvath, Altos Labs
• Hussain Ahamed, Ultrahuman
Epigenetic Aging Signatures in Large Human Cohorts
• Varun Dwaraka, TruDiagnostic
AI Systems for Personalized Longevity: How Biomarkers Translate into Actionable Interventions
• Chair: Nathan Price, Buck Institute
• Sherry Zhang, Buck Institute
• Ranjan Sinha, Digbi Health
• Zeenia Framroze, Alethios, Inc.
Telomere Extension Clinical Trials Under LARTA/FDA
• John Ramunas, Rejuvenation Technologies
Clinical Trial Design & Functional Endpoints for Healthspan
• Nir Barzilai, Albert Einstein College of Mediciney
The data We Need For AI To Accelerate Longevity Drugs
• Martin Jensen, Gordian Biotechnology
From Genome to an AI-Drive Longevity Platform
• Wei-Wu He, Human Longevity
Wellness Wearables: The Journey to Clinical
• Hussain Ahamed, Ultrahuman
Longevity Medicine: Ambition vs Evidence in the Era of Precision Health
• Aubrey de Grey, LEV Foundation
Precision Aging & Longevity Focused on Limited Lifespan Evidence, Vanishing Blue Zones, and Payer ROI
• S. Jay Olshansky, University of Illinois
Evolutionary perspectives on human lifespan and healthspan
• Michael Gurven, UC Santa Barbara




